Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

BACKGROUND: Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients with left ventricular systolic dysfunction in randomized trials. Competing death without prior appropriate ICD therapy might preclude benefit from ICD implantation in a less selected routine-care popula...

Full description

Bibliographic Details
Main Authors:	Koller, M, Schaer, B, Wolbers, M, Sticherling, C, Bucher, H, Osswald, S
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Response to letter regarding article, "Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study"
by: Koller, M, et al.
Published: (2008)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
by: Mohammad Reza Dehghani, et al.
Published: (2006-01-01)

Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
by: Dennis W. Zhu, et al.
Published: (2010-02-01)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
by: Katherine C. Wu, et al.
Published: (2020-10-01)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
by: Sirin Apiyasawat, et al.
Published: (2014-01-01)

Implantable cardioverter defibrillators in the prevention of sudden cardiac death
by: L A Bockeria, et al.
Published: (2017-12-01)

Right Bundle Branch Block Predicts Appropriate Implantable Cardioverter Defibrillator Therapies in Patients with Non-Ischemic Dilated Cardiomyopathy and a Prophylactic Implantable Cardioverter Defibrillator
by: Marta Jiménez-Blanco Bravo, et al.
Published: (2024-06-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
by: Matthew F. Yuyun, MD, MPhil, PhD, et al.
Published: (2020-05-01)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

Factors influencing the status of appropriate and inappropriate shocks delivered by an implantable cardioverter defibrillator
by: Vahid Ghavami Ghanbarabadi, et al.
Published: (2013-05-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
by: Marit van Barreveld, et al.
Published: (2021-04-01)

Persistent improvement of ejection fraction in patients with a cardiac resynchronisation therapy defibrillator correlates with fewer appropriate ICD interventions and lower mortality
by: Beat Schaer, et al.
Published: (2016-03-01)

Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis.
by: David Conen, et al.
Published: (2016-01-01)

Paradox of Appropriate Implantable Cardioverter‐Defibrillator Therapy: Saving Lives But Revealing an Increased Mortality Risk
by: Ryan G. Aleong, et al.
Published: (2017-08-01)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
by: Abdulkadir Uslu, et al.
Published: (2019-03-01)

Automatic implantable cardioverter defibrillator: when not to implant
by: Maria Teresa La Rovere, et al.
Published: (2020-02-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Externalized biventricular implantable cardioverter-defibrillator
by: Sofia Lázaro Mendes, et al.
Published: (2016-04-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

In response to, ′Magnets and implantable cardioverter defibrillators′
by: Somsri Wiwanitkit, et al.
Published: (2013-01-01)

Outcome of patients with cardiac resynchronisation defibrillator therapy and a follow-up of at least five years after implant
by: Matthias Bossard, et al.
Published: (2014-02-01)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
by: Venkata M. Alla, et al.
Published: (2010-01-01)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
by: Luis A. Pires
Published: (2007-08-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)

Cost-Effectiveness of Cardioverter-Defibrillator Implantation in Kazakhstan
by: Begisbayev T, et al.
Published: (2022-10-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
by: Gabriela M. Orgeron, et al.
Published: (2017-11-01)

Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
by: Kenan Yalta, MD, et al.
Published: (2022-09-01)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
by: David Duncker, et al.
Published: (2017-01-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
by: Ryan T. Borne, et al.
Published: (2017-03-01)

Nutritional Status Is Associated with Mortality but Not Appropriate Discharge of Implantable Cardioverter Defibrillators in Patients with Heart Failure
by: Idris Yakut, et al.
Published: (2025-03-01)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
by: Marc Strik, et al.
Published: (2023-10-01)